CLOV vs CRL · rev $1.37B vs rev $4.05B
Clover Health Investments Corp (CLOV) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported CRL revenue for 2024-12-28 was $4.05B. Net income was $25.3M. Revenue was down 1.9% from 2023-12-30 to 2024-12-28. CRL currently screens at market cap $7.78B.
CLOV currently screens at market cap $1.55B. CRL currently screens at market cap $7.78B.
Not investment advice. Open the CLOV and CRL stock pages for the full models.
Not investment advice.